Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07084285

Cervical Facet Injection of Corticosteroids for the Management of Cervicobrachialgia

Cervical Facet Injection of Corticosteroids for the Management of Cervicobrachialgia : Protocol for a Randomized Pilot Study

Status
Not Yet Recruiting
Phase
Phase 3
Study type
Interventional
Enrollment
70 (estimated)
Sponsor
Assistance Publique - Hôpitaux de Paris · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The main objective is to evaluate the efficacy of a single posterior intra-articular injection of dexamethasone on radicular pain (RP) at 1 month in the treatment of uncomplicated chronic cervicobrachial neuralgia (CBN) in adults, resistant to well-conducted first-line medical treatment.

Detailed description

Cervicobrachial Neuralgia (CBN) is a common condition caused by the compression of a nerve root (C5, C6, C7, or C8) in the cervical spine. In 10% of cases, the duration of symptoms exceeds 3 months, at which point it is considered chronic. Two main etiologies are distinguished : * Soft disc herniation, * uncodiscarthrotic foraminal stenosis. The pathophysiology involves both mechanical compression and local inflammation. The initial management is typically medical, provided if there are no signs of severity. If medical treatment fails or if signs of severity are present, surgical intervention is required. The role of corticosteroid injections in the therapeutic strategy in France remains controversial. Literature on the efficacy of cervical spinal injections is heterogeneous and limited, the safety of such injections is debated, and product availability is restricted. We hypothesize that posterior intra-articular dexamethasone injection would be effective for radicular pain resistant to first-line medical treatment.

Conditions

Interventions

TypeNameDescription
DRUGDexamethasoneA single 4mg (1mL) dexamethasone injection via the posterior intra-articular route, under CT guidance
OTHERIsotonic saline solution1 mL isotonic saline solution, injectable, for a single posterior intra-articular injection, under CT guidance.

Timeline

Start date
2026-01-01
Primary completion
2028-02-01
Completion
2028-05-01
First posted
2025-07-24
Last updated
2025-08-12

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT07084285. Inclusion in this directory is not an endorsement.